Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1871769
Title:
DES FORMES CRISTALLINES DU COMPOSÉ 4-(6-CHLORO-2,3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
058181272
WO application number:
GB2005004807
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
1871769
WO publication number:
WO2006064217
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
14/12/2005
Grant date:
22/02/2017
EP publication date:
02/01/2008
WO publication date:
22/06/2006
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/02/2017
EP B1 publication date:
22/02/2017
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/12/2017
Expiration date (if granted and all annual fees paid):
14/12/2025
Applicant
Name:
AstraZeneca AB
Legal Form:
From:
22/02/2017
Address:
151 85 Södertälje, Sweden (SE)
To:
Inventor
1
Name:
FORD, James Gair
AstraZeneca
Legal Form:
Address:
Macclesfield
Cheshire SK10 2NA, United Kingdom (GB)
2
Name:
MCCABE, James Francis
AstraZeneca
Legal Form:
Address:
Macclesfield
Cheshire SK10 2NA, United Kingdom (GB)
3
Name:
O'KEARNEY-MCMULLAN, Anne
AstraZeneca
Legal Form:
Address:
Macclesfield
Cheshire SK10 2NA, United Kingdom (GB)
4
Name:
O'KEEFE, Philip
AstraZeneca R & D Charnwood
Legal Form:
Address:
Loughborough
Leicestershire LE11 5RH, United Kingdom (GB)
5
Name:
POINTON, Simon Mark
AstraZeneca
Legal Form:
Address:
Maccl esfield
Cheshire SK10 2NA, United Kingdom (GB)
6
Name:
POWELL, Lyn
AstraZeneca
Legal Form:
Address:
Macclesfield
Cheshire SK10 2NA, United Kingdom (GB)
7
Name:
PURDIE, Mark
AstraZeneca R & D Charnwood
Legal Form:
Address:
Loughborough
Leicestershire LE11 5RH, United Kingdom (GB)
8
Name:
WITHNALL, Jane
AstraZeneca R & D Charnwood
Legal Form:
Address:
Loughborough
Leicestershire LE11 5RH, United Kingdom (GB)